Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.

Leitão R, Guerreiro C, Nunes RG, Gonçalves N, Galati G, Rosário M, Guedes LC, Ferreira JJ, Reimão S.

J Huntingtons Dis. 2020 Feb 12. doi: 10.3233/JHD-190388. [Epub ahead of print]

PMID:
32065802
2.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Jul;64:73-81. doi: 10.1016/j.parkreldis.2019.02.043. Epub 2019 Mar 2.

PMID:
30902528
3.

Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.

Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M, Miltenberger-Miltényi G, Borovecki F, Soreq H, Ferreira JJ, Outeiro TF.

PLoS One. 2017 Dec 28;12(12):e0190552. doi: 10.1371/journal.pone.0190552. eCollection 2017.

4.

Serum lipid alterations in GBA-associated Parkinson's disease.

Guedes LC, Chan RB, Gomes MA, Conceição VA, Machado RB, Soares T, Xu Y, Gaspar P, Carriço JA, Alcalay RN, Ferreira JJ, Outeiro TF, Miltenberger-Miltenyi G.

Parkinsonism Relat Disord. 2017 Nov;44:58-65. doi: 10.1016/j.parkreldis.2017.08.026. Epub 2017 Sep 1.

PMID:
28890071
5.

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.

Fabbri M, Guimarães I, Cardoso R, Coelho M, Guedes LC, Rosa MM, Godinho C, Abreu D, Gonçalves N, Antonini A, Ferreira JJ.

Front Neurol. 2017 Aug 22;8:432. doi: 10.3389/fneur.2017.00432. eCollection 2017.

6.

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.

Fabbri M, Reimão S, Carvalho M, Nunes RG, Abreu D, Guedes LC, Bouça R, Lobo PP, Godinho C, Coelho M, Gonçalves NC, Rosa MM, Antonini A, Ferreira JJ.

J Parkinsons Dis. 2017;7(3):491-501. doi: 10.3233/JPD-171135.

PMID:
28671143
7.

Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.

Fabbri M, Coelho M, Guedes LC, Rosa MM, Abreu D, Gonçalves N, Antonini A, Ferreira JJ.

Parkinsonism Relat Disord. 2017 Aug;41:113-117. doi: 10.1016/j.parkreldis.2017.05.003. Epub 2017 May 8.

PMID:
28528805
8.

Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.

Fabbri M, Coelho M, Guedes LC, Chendo I, Sousa C, Rosa MM, Abreu D, Costa N, Godinho C, Antonini A, Ferreira JJ.

Parkinsonism Relat Disord. 2017 Jun;39:37-43. doi: 10.1016/j.parkreldis.2017.02.007. Epub 2017 Feb 7.

PMID:
28389156
9.

Mutations in TMEM230 are not a common cause of Parkinson's disease.

Quadri M, Breedveld GJ, Chang HC, Yeh TH, Guedes LC, Toni V, Fabrizio E, De Mari M, Thomas A, Tassorelli C, Rood JP, Saddi V, Chien HF, Kievit AJ, Boon AJ, Stocchi F, Lopiano L, Abbruzzese G, Cortelli P, Meco G, Cossu G, Barbosa ER, Ferreira JJ; International Parkinsonism Genetics Network, Lu CS, Bonifati V.

Mov Disord. 2017 Feb;32(2):302-304. doi: 10.1002/mds.26900. Epub 2017 Jan 16. No abstract available.

PMID:
28090676
10.

Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.

Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M, Miltenberger-Miltényi G, Borovecki F, Soreq H, Ferreira JJ, F Outeiro T.

PLoS One. 2016 Jun 20;11(6):e0157852. doi: 10.1371/journal.pone.0157852. eCollection 2016. Erratum in: PLoS One. 2017 Dec 28;12 (12 ):e0190552.

11.

Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials.

Ferreira JJ, Mestre T, Guedes LC, Coelho M, Rosa MM, Santos AT, Barra M, Sampaio C, Rascol O.

Front Neurol. 2016 Mar 8;7:27. doi: 10.3389/fneur.2016.00027. eCollection 2016.

12.

Do patients with late-stage Parkinson's disease still respond to levodopa?

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Costa N, Antonini A, Ferreira JJ.

Parkinsonism Relat Disord. 2016 May;26:10-6. doi: 10.1016/j.parkreldis.2016.02.021. Epub 2016 Feb 26.

PMID:
26972527
13.

Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.

Reimão S, Pita Lobo P, Neutel D, Guedes LC, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ.

J Parkinsons Dis. 2015;5(3):561-7. doi: 10.3233/JPD-150551.

PMID:
26406136
14.

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.

Reimão S, Pita Lobo P, Neutel D, Guedes LC, Coelho M, Rosa MM, Azevedo P, Ferreira J, Abreu D, Gonçalves N, Nunes RG, Campos J, Ferreira JJ.

Mov Disord. 2015 Jun;30(7):953-9. doi: 10.1002/mds.26182. Epub 2015 Mar 11.

PMID:
25758364
15.

An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate.

Quadri M, Yang X, Cossu G, Olgiati S, Saddi VM, Breedveld GJ, Ouyang L, Hu J, Xu N, Graafland J, Ricchi V, Murgia D, Guedes LC, Mariani C, Marti MJ, Tarantino P, Asselta R, Valldeoriola F, Gagliardi M, Pezzoli G, Ezquerra M, Quattrone A, Ferreira J, Annesi G, Goldwurm S, Tolosa E, Oostra BA, Melis M, Wang J, Bonifati V.

Neurogenetics. 2015 Jan;16(1):55-64. doi: 10.1007/s10048-014-0425-x. Epub 2014 Oct 8.

PMID:
25294124
16.

Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease.

Fabbri M, Guedes LC, Coelho M, Simão D, Abreu D, Rosa MM, Silveira-Moriyama L, Ferreira JJ.

Eur J Neurol. 2015 Jan;22(1):207-10. doi: 10.1111/ene.12396. Epub 2014 Mar 6.

PMID:
24602222
17.

STN-DBS does not change emotion recognition in advanced Parkinson's disease.

Albuquerque L, Coelho M, Martins M, Guedes LC, Rosa MM, Ferreira JJ, Cattoni MB, Carvalho H, Ferreira AG, Martins IP.

Parkinsonism Relat Disord. 2014 Feb;20(2):166-9. doi: 10.1016/j.parkreldis.2013.10.010. Epub 2013 Oct 18.

PMID:
24182523
18.

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.

Zhang L, Quadri M, Guedes LC, Coelho M, Valadas A, Mestre T, Lobo PP, Rosa MM, Simons E, Oostra BA, Ferreira JJ, Bonifati V.

Parkinsonism Relat Disord. 2013 Oct;19(10):897-900. doi: 10.1016/j.parkreldis.2013.05.003. Epub 2013 May 28.

PMID:
23726462
19.

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.

Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, Oliveira SA.

PLoS One. 2011;6(10):e25443. doi: 10.1371/journal.pone.0025443. Epub 2011 Oct 7.

20.

What motivates Parkinson's disease patients to enter clinical trials?

Valadas A, Coelho M, Mestre T, Guedes LC, Finisterra M, Noronha A, Rosa MM, Sampaio C, Ferreira JJ.

Parkinsonism Relat Disord. 2011 Nov;17(9):667-71. doi: 10.1016/j.parkreldis.2011.05.023. Epub 2011 Jun 28.

PMID:
21715213
21.

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ.

Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45.

PMID:
18809839
22.

A systematic review of immediate anticoagulation for ischemic stroke of presumed cardioembolic origin.

Guedes LC, Ferro JM.

Stroke. 2008 May;39(5):e81-2; author reply e83. doi: 10.1161/STROKEAHA.107.513200. Epub 2008 Mar 27. No abstract available.

PMID:
18369164
23.

Skin cancers and precancerous lesions in Parkinson's disease patients.

Ferreira J, Silva JM, Freire R, Pignatelli J, Guedes LC, Feijó A, Rosa MM, Coelho M, Costa J, Noronha A, Hewett R, Gomes AM, de Castro JL, Rascol O, Sampaio C.

Mov Disord. 2007 Jul 30;22(10):1471-5.

PMID:
17516496
24.

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.

Ferreira JJ, Guedes LC, Rosa MM, Coelho M, van Doeselaar M, Schweiger D, Di Fonzo A, Oostra BA, Sampaio C, Bonifati V.

Mov Disord. 2007 Jun 15;22(8):1194-201.

PMID:
17469194

Supplemental Content

Loading ...
Support Center